The year 2020 will be remembered, not only for the pandemic but also for the promising advances in therapy for advanced bladder, prostate, and renal cell carcinoma (RCC) . AstraZeneca Medical Team and Docplexus are organizing an interactive webinar with distinguished panelists to discuss the “Evolving Treatment Landscape Of Metastatic Castration Resistant Prostate Cancer” on 23 rd October 2020 at 07:00 PM.
Agenda: mCRPC: metastatic castration-resistant prostate cancer; HRRm: homologous recombination repair gene mutations We invite you to share your questions here; the speaker shall answer them at the end of the session.
